-$0.41 (-0.78%) As of 11:46 AM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pfizer and other ETFs, options, and stocks.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.

Albert Bourla
New York, New York

PFE Key Statistics

Market cap
Price-Earnings ratio
Dividend yield
Average volume
High today
Low today
Open price
52 Week high
52 Week low

PFE News

ReutersJul 3

German health minister in move to boost use of COVID treatment Paxlovid - Reuters

Pfizer's coronavirus disease (COVID-19) pill Paxlovid is packaged in Ascoli, Italy, in this undated image obtained by Reuters on November 16, 2021. Pfizer/Hando
BenzingaJun 30

Why Pfizer Stock Is Rising Today

Pfizer Inc PFE shares are trading higher Thursday after the company and BioNTech SE BNTX announced a new COVID-19 vaccine supply agreement with the U.S. governm
BenzingaJun 30

This Analyst Says US Government Buying More COVID-19 Vaccines At Higher Prices

Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) announced a new COVID-19 vaccine supply agreement with the U.S. government. SVB Leerink says that the new

PFE Earnings

Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
— per share
Available Jul 28, Pre-Market

More PFE News

ReutersJun 30

UPDATE 1-Pfizer asks for formal U.S. approval of oral COVID treatment Paxlovid

(Adds analyst comment, background) June 30 (Reuters) - Pfizer Inc said on Thursday it is seeking full U.S. approval for its oral COVID-19 antiviral treatment P
BenzingaJun 30

Pfizer Seeks Complete Approval For Paxlovid For High Risk COVID-19 Patients

by Pfizer Inc PFE has submitted a new drug application to the FDA for the approval of Paxlovid for patients at high risk for progression to severe illness from
Barron'sJun 30

FDA Asks Vaccine Makers for Boosters to Target BA.5

Text size The Food and Drug Administration on Thursday asked Covid-19 vaccine makers to produce boosters for the fall that target the BA.4/BA.5 Omicron subvari
Barron'sJun 30

Pfizer Raises Vaccine Price 27%. What It Means for the Stock.

Text size Pfizer has raised the U.S. price of its Covid-19 vaccine, in another sign that investors may be underestimating the durability of its Covid-19 vaccin
The Wall Street JournalJun 30

Pfizer Seeks FDA’s Full Approval for Paxlovid Covid-19 Pill - The Wall Street Journal

Pfizer Inc. has asked the Food and Drug Administration to grant full approval of its Covid-19 antiviral pill, a step toward allowing the drugmaker to sell the d
ReutersJun 29

Pfizer signs $3.2 bln deal with U.S. government for COVID vaccine doses

June 29 (Reuters) - Pfizer Inc and BioNTech said on Wednesday they had signed a $3.2 billion deal with the U.S. government for 105 million doses of their COVID-
Simply Wall StJun 29

These 4 Measures Indicate That Pfizer Is Using Debt Safely

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the vol
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure